Ultravist 300mg I/ml Injection
By Ultravist
Rx
50ml Injection in a Vial

Composition
Iopromide(300mg I/ml)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
August, 2025

liver
When using Ultravist 300mg I/ml Injection, caution is advised in patients with severe liver disease. It may be necessary to adjust the dosage of Ultravist 300mg I/ml Injection in such cases. It is recommended to consult your doctor before using this medication if you have liver issues.

kidney
Ultravist 300mg I/ml Injection requires caution in patients with severe kidney disease. Dosage adjustment may be necessary. Consult your doctor before use.

alcohol
"Consult your doctor when consuming alcohol with Ultravist 300mg I/ml Injection."

driving
It is not certain if Ultravist 300mg I/ml Injection affects driving ability. Avoid driving if you have symptoms that hinder focus and reaction time.

pregnancy
Ultravist 300mg I/ml Injection is generally considered safe for use during pregnancy. Animal studies have shown limited adverse effects on the baby, with low risk. Human studies are limited.

breastfeeding
Caution It is probably unsafe to use Ultravist 300mg I/ml Injection while breastfeeding. Limited data indicates the drug may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | 4-Halobenzoic Acids Derivative |
Therapeutic Class | - |
Action Class | X ray contrast media (Diagnostic agents) |
₹853.45
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025